Kimberly Blackwell's Net Worth
$1.76 Million
Who is Kimberly Blackwell?
Kimberly Blackwell has an estimated net worth of $1.76 Million. This is based on reported shares across multiple companies, which include Zentalis Pharmaceuticals, Inc., Monte Rosa Therapeutics, Inc., and Century Therapeutics, Inc..
SEC CIK
Kimberly Blackwell's CIK is 0001816465
Past Insider Trading and Trends
2021 was Kimberly Blackwell's most active year for acquiring shares with 8 total transactions. Kimberly Blackwell's most active month to acquire stocks was the month of May. 2021 was Kimberly Blackwell's most active year for disposing of shares, totalling 6 transactions. Kimberly Blackwell's most active month to dispose stocks was the month of December. 2023 saw Kimberly Blackwell paying a total of $51,448.00 for 669,500 shares, this is the most they've acquired in one year. In 2024 Kimberly Blackwell cashed out on 20,655 shares for a total of $241,456.95, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Zentalis Pharmaceuticals, Inc. (ZNTL) Snapshot price: $2.96
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +90.01% | 229.34K |
$11.69 | -$241,456.95 | 484.14K |
Feb 1
| |||
Form 4
| +2.00% | 5K |
$10.29 | $51,448.00 | 254.8K |
Nov 13
| |||
Form 4
| +4,896.00% | 244.8K |
—
|
—
| 249.8K |
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
|
—
|
0
|
$65.77 | -$35,940.00 | 5K |
Scheduled
|
Jan 3
| ||
Form 4
|
—
|
0
|
$64.82 | -$34,040.00 | 5K |
Scheduled
|
Dec 1
| ||
Form 4
|
—
|
0
|
$64.13 | -$32,660.00 | 5K |
Scheduled
|
Nov 1
| ||
Form 4
|
—
|
0
|
$62.70 | -$29,790.00 | 5K |
Scheduled
|
Oct 25
| ||
Form 4
|
∞
| 5K |
—
|
—
| 5K |
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Monte Rosa Therapeutics, Inc. (GLUE) Snapshot price: $5.69
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 12 - Jun 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Century Therapeutics, Inc. (IPSC) Snapshot price: $1.44
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||